For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

Join this seminar on December 13, 2021 from 15:30 - 17:00 CET. Register below.

The European Medicines Agency plays a central role in the regulation of Europe’s medicines supply. The Coronavirus pandemic has led the EU to expand and strengthen the EMA’s powers in pharmaceutical policy. This is happening against the backdrop of globalization, where the EMA is both influenced by and impacting on pharmaceutical policy far beyond its borders. This seminar unpacks and discusses these issues from the perspective of law and governance.


Moderated by Ms. Pramiti Parwani, Law Centre for Health and Life, University of Amsterdam


Dr. Katrina PerehudoffSenior Research Fellow, Law Centre for Health and Life, University of Amsterdam

Dr. Sabrina Röttger-WirtzAssistant Professor of EU Law, Faculty of Law, Maastricht University

Mr. Martin Harvey AllchurchHead of International Affairs, European Medicines Agency

Ms. Ancella Santos QuintanoSenior Health Policy Officer, The European Consumers Organisation

Dr. Elena PetelosVice President HTA, EUPHA and Co-Chair RWE & AI, HTAi

This event is organised by the University of Amsterdam's Law Centre for Health and Life, the Amsterdam Centre for European Law and Governance, and the Amsterdam Centre for European Studies; the Amsterdam Institute for Global Health and Development; and the European Public Health Association sections on 'Law and Public Health' and on 'Health Technology Assessment'.